Maternal Serum and Umbilical Cord Brain Natriuretic Peptide Levels in Fetuses with Intrauterine Growth Restriction

References

• Kucukbas GN, Kara O, Yüce D, Uygur D. Maternal plasma endocan levels in intrauterine growth restriction. J Matern Fetal Neonatal Med. 2020;14:1–6. doi:10.1080/14767058.2020.1749591. Epub ahead of print. PMID: 32290736.
   Google Scholar
• Eroglu H, Turgal M, Senat A, et al. Maternal and fetal thiol/disulphide homeostasis in fetal growth restriction. J Maternal Fetal Neonat Med. 2021;34(10):1658–65. doi:10.1080/14767058.2019.1646239.
   PubMed Web of Science ®Google Scholar
• Baschat AA. Neurodevelopment after fetal growth restriction. Fetal Diagn Ther. 2014;36(2):136–42. doi:10.1159/000353631. PubMed PMID: 23886893
   PubMed Web of Science ®Google Scholar
• Nardozza LMM, Caetano ACR, Zamarian ACP, Mazzola JB, Silva CP, Marçal VMG, Lobo TF, Peixoto AB, Araujo Júnior E. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295(5):1061–77. doi:10.1007/s00404-017-4341-9.
   PubMed Web of Science ®Google Scholar
• Levine TA, Grunau RE, McAuliffe FM, Pinnamaneni R, Foran A, Alderdice FA. Early childhood neurodevelopment after intrauterine growth restriction: a systematic review. Pediatrics. 2015;135(1):126–41. doi:10.1542/peds.2014-1143.
   PubMed Web of Science ®Google Scholar
• Suhag A, Berghella V. Intrauterine growth restriction (IUGR): etiology and diagnosis. Curr Obstet Gynecol Rep. 2013;2(2):102–11. doi:10.1007/s13669-013-0041-z.
   Google Scholar
• Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultras Obstet Gynecol. 2016;48(3):333–9. doi:10.1002/uog.15884.
   PubMed Web of Science ®Google Scholar
• Kumari M, Tang WH, Maroo AP. Natriuretic peptide testing in high-risk pregnancy: a preventive opportunity?Curr Heart Fail Rep. 2014;11(4):471–6. [PubMed: 25260544] doi:10.1007/s11897-014-0228-2.
   PubMedGoogle Scholar
• Troughton R, Michael Felker G, Januzzi JL. Natriuretic peptide-guided heart failure management. Eur Heart J. 2014;35(1):16–24. doi:10.1093/eurheartj/eht463.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, ESC Scientific Document Group, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC). Eur Heart J. 2016;37(27):2129–200. doi:10.1093/eurheartj/ehw128.
   PubMed Web of Science ®Google Scholar
• Suttner S, Boldt J. Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care. 2004;10(5):336–41. [PubMed: 15385748] doi:10.1097/01.ccx.0000135513.26376.4f.
   PubMedGoogle Scholar
• Maalouf R, Bailey S. A review on B-type natriuretic peptide monitoring: assays and biosensors. Heart Fail Rev. 2016;21(5):567–78. doi:10.1007/s10741-016-9544-9.
   PubMed Web of Science ®Google Scholar
• De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362(9380):316–22. doi:10.1016/S0140-6736(03)13976-1.
   PubMed Web of Science ®Google Scholar
• Sadlecki P, Grabiec M, Walentowicz-Sadlecka M. Prenatal clinical assessment of NTproBNP as a diagnostic tool for preeclampsia, gestational hypertension and gestational diabetes mellitus. PLoS One. 2016;11(9):e0162957. doi:10.1371/journal.pone.0162957.
   PubMed Web of Science ®Google Scholar
• Bae JY, Seong WJ. Umbilical arterial N-terminal pro-B-type natriuretic peptide levels in preeclampsia, fetal growth restriction, preterm birth and fetal distress. Clin Exp Obstet Gynecol. 2016;43(3):393–6.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics and the Society for Maternal-Fetal Medicin. ACOG Practice Bulletin No. 204: Fetal Growth Restriction. Obstet Gynecol. 2019;133(2):e97–e109. doi:10.1097/AOG.0000000000003070. PMID: 30681542.
   PubMed Web of Science ®Google Scholar
• Jansson T, Powell T. Award in placentology lecture. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? – a review. Placenta. 2006;27:91–7. doi:10.1016/j.placenta.2005.11.010.
   PubMed Web of Science ®Google Scholar
• Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta. 2009;30:77–82. doi:10.1016/j.placenta.2008.12.006.
   PubMed Web of Science ®Google Scholar
• Longo S, Bollani L, Decembrino L, Di Comite A, Angelini M, Stronati M. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med. 2013;26(3):222–5. doi:10.3109/14767058.2012.715006.
   PubMed Web of Science ®Google Scholar
• Colella M, Frérot A, Novais ARB, Baud O. Neonatal and long-term consequences of fetal growth restriction. Curr Pediatr Rev. 2018;14(4):212–8. doi:10.2174/1573396314666180712114531. PMID: 29998808; PMCID: PMC6416241.
   PubMed Web of Science ®Google Scholar
• Unterscheider J, O’Donoghue K, Daly S, Geary MP, Kennelly MM, McAuliffe FM, Hunter A, Morrison JJ, Burke G, Dicker P, et al. Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study. BMC Pregnancy Childbirth. 2014;14(1):63. doi:10.1186/1471-2393-14-63.
   PubMedGoogle Scholar
• Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol. 2011;58(4):337–50. doi:10.1016/j.jacc.2011.04.014.
   PubMed Web of Science ®Google Scholar
• Franz MB, Franz MB, Andreas M, Schiessl B, Zeisler H, Neubauer A, Kastl SP, Hess G, Rhomberg F, Zdunek D, et al. NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls. Acta Obstet Gynecol Scand. 2009;88(2):234–7. doi:10.1080/00016340802596025.
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J. 2015;36(18):1090–7. doi:10.1093/eurheartj/ehv009.
   PubMed Web of Science ®Google Scholar
• Li W, Li H, Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy. Can J Cardiol. 2016;32(3):362–8. doi:10.1016/j.cjca.2015.07.733.
   PubMed Web of Science ®Google Scholar
• Szabó G, Molvarec A, Nagy B, Rigó J.Jr. Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia. Clin Chem Lab Med. 2014;52(2):281–8.
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med. 1992;326(14):927–32. doi:10.1056/NEJM199204023261405.
   PubMed Web of Science ®Google Scholar
• Onalan G, Terzi YK, Tohma YA, Yurtcu E, Kuscu E, Sahin FI, Zeyneloglu HB. Placental maspin gene expression pattern may be used to distinguish between preeclampsia and intrauterine growth restriction. Gynecol Obstet Reprod Med. 2020;1–5. doi:10.21613/GORM.2019.969.
   Google Scholar
• Giannubilo SR, Pasculli A, Tidu E, Biagini A, Boscarato V, Ciavattini A. Relationship between maternal hemodynamics and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia and fetal growth restriction. J Perinatol. 2017;37(5):484–7. doi:10.1038/jp.2016.264.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Figueras F, Eleftheriades M, Papaioannou GK, Chorozoglou G, Dinas K, Papantoniou N. First‐trimester and combined first‐ and second‐trimester prediction of small‐for‐gestational age and late fetal growth restriction. Ultras Obstet Gynecol. 2019;53(1):55–61. Epub 2018 Nov 26.PMID: 29573501 doi:10.1002/uog.19055.
   PubMed Web of Science ®Google Scholar
• He B, Hu C, Zhou Y. First-trimester screening for fetal growth restriction using Doppler color flow analysis of the uterine artery and serum PAPP-A levels in unselected pregnancies. J Matern Fetal Neonatal Med. 2020;12:1–5. doi:10.1080/14767058.2019.1701646. Epub ahead of print. PMID: 31928253.
   Google Scholar
• Yu N, Cui H, Chen X, Chang Y. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction. Taiwan J Obstet Gynecol. 2017;56(3):358–61. doi:10.1016/j.tjog.2017.01.009. PMID: 28600048
   PubMed Web of Science ®Google Scholar
• Johansson S, Iliadou A, Bergvall N, Tuvemo T, Norman M, Cnattingius S. Risk of high blood pressure among young men increases with the degree of immaturity at birth. Circulation. 2005; 112(22):3430–6. doi:10.1161/CIRCULATIONAHA.105.540906.
   PubMed Web of Science ®Google Scholar
• Brodszki J, Länne T, Marsál K, Ley D. Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation. 2005; 111(20):2623–8. doi:10.1161/CIRCULATIONAHA.104.490326.
   PubMed Web of Science ®Google Scholar
• Skilton MR, Evans N, Griffiths KA, Harmer JA, Celermajer DS. Aortic wall thickness in newborns with intrauterine growth restriction. Lancet. 2005; 365(9469):1484–6. doi:10.1016/S0140-6736(05)66419-7.
   PubMed Web of Science ®Google Scholar
• Bacchetta J, Harambat J, Dubourg L, Guy B, Liutkus A, Canterino I, Kassaï B, Putet G, Cochat P. Both extrauterine and intrauterine growth restriction impair renal function in children born very preterm. Kidney Int. 2009; 76(4):445–52. doi:10.1038/ki.2009.201.
   PubMed Web of Science ®Google Scholar